Liposomal curcumin inhibits hypoxia-induced angiogenesis after transcatheter arterial embolization in VX2 rabbit liver tumors

Feng Dai1 The First College of Clinical Medicine, Nanjing University of Chinese Medicine, Nanjing, People’s Republic of China;2 Department of Interventional Radiology, The Second Hospital of Nanjing, Medical School, Southeast University, Nanjing, People’s Republic of China

Xiuming Zhang3 Department of Radiology, Nanjing University of Chinese Medicine, Nanjing, People’s Republic of China

Wenrong Shen3 Department of Radiology, Nanjing University of Chinese Medicine, Nanjing, People’s Republic of China

Jun Chen4 Department of Interventional Radiology, Jiangsu Province Tumor Hospital, Nanjing University of Chinese Medicine, Nanjing, People’s Republic of China

Liucheng Liu5 Department of Pharmacy, Jiangsu Aosakang Pharmaceutical Co. Ltd, Nanjing University of Chinese Medicine, Nanjing, People’s Republic of China

Gejun Gao6 Department of Radiology, Jiangsu Province Hospital of TCM, Nanjing University of Chinese Medicine, Nanjing, People’s Republic of ChinaCorrespondence[email protected]

Pages 2601-2611 | Published online: 15 Sep 2015

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

ShermanMHepatocellular carcinoma: epidemiology, risk factors and screeningSemin Liver Dis200525214315415918143
PubMed Web of Science ®Google Scholar
LllovetJMSchwartzMMazzaferroVResection and liver transplantation for hepatocellular carcinomaSemin Liver Dis200525218120015918147
PubMed Web of Science ®Google Scholar
BreedisCYoungGThe blood supply of neoplasms in the liverAm J Pathol195430596997713197542
PubMed Web of Science ®Google Scholar
BrownDBGouldJEGervaisDATranscatheter therapy for hepatic malignancy: standardization of terminology and reporting criteriaJ Vasc Interv Radiol200718121469147818057279
PubMed Web of Science ®Google Scholar
LlovetJMRealMIMontañaXBarcelona Liver Cancer GroupArterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trialLancet200235993191734173912049862
PubMed Web of Science ®Google Scholar
SemenzaGLHIF-1 and tumor progression: pathophysiology and therapeuticsTrends Mol Med200284626711815271
PubMed Web of Science ®Google Scholar
VirmaniSRheeTKRyuRKSatoKTLewandowskiRJComparison of hypoxia-inducible factor-1 alpha expression before and after transcatheter arterial embolization in rabbit VX2 liver tumorsJ Vasc Inter Radiol2008191014831489
Web of Science ®Google Scholar
LiangBZhengCSFengGSCorrelation of hypoxia-inducible factor 1 alpha with angiogenesis in liver tumors after transcatheter arterial embolization in an animal mode lCardivasc Intervent Radiol2010334806812
PubMed Web of Science ®Google Scholar
ShahnehFZBaradaranBZamaniFAghebati-MalekiLTumor angiogenesis and anti-angiogenic therapiesHum Antibodies2013221–2151924284305
PubMedGoogle Scholar
VerheulHMPinedoHMPossible molecular mechanisms involved in toxicity of angiogenesis inhibitionNat Rev Cancer20077647548517522716
PubMed Web of Science ®Google Scholar
JiaZZJiangGMFengYLSerum HIF-1 alpha and VEGF levels pre- and post-TACE in patients with primary liver cancerChin Med Sci J201126315816222207924
PubMedGoogle Scholar
BaeMKKimSHJeongJWCurcumin inhibits hypoxia-induced angiogenesis via down-regulation of HIF-1Oncol Rep20061561557156216685395
PubMed Web of Science ®Google Scholar
ShehzadALeeJLeeYSCurcumin in various cancerBiofactors2013391566823303705
PubMed Web of Science ®Google Scholar
LiLBraitehFSKurzrockRLiposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesisCancer200510461322133116092118
PubMed Web of Science ®Google Scholar
ChenCJohnstonTDJeonHAn in vitro study of liposomal curcumin: stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cellsInt J Pharm20093661–213313918840516
PubMed Web of Science ®Google Scholar
MoreiraPLAnYHAnimal models for therapeutic embolizationCardiovasc Intervent Radiol200326210011012677466
PubMed Web of Science ®Google Scholar
ZhongHDe MarzoAMLaughnerEOverexpression of hypoxia-inducible factor 1 in common human cancers and their metastasesCaner Res1999592258305835
PubMed Web of Science ®Google Scholar
YamaguchiRYanoHLemuraAOgasawaraSHaramakiMKojiroMExpression of vascular endothelial growth factor in human hepatocellular carcinomaHepatology199828168779657098
PubMed Web of Science ®Google Scholar
WeidnerNSempleJPWelchWRFolkmanJTumor angiogenesis and metastasis-correlation in invasive breast carcinomaN Engl J Med19913241181701519
PubMed Web of Science ®Google Scholar
BupathiMKasebAJankuFAngiopoietin 2 as a therapeutic target in hepatocellular carcinoma treatment: current perspectivesOnco Targets Ther201471927193225364263
PubMed Web of Science ®Google Scholar
YadawVRAqqarwalBBCurcumin: a component of the golden spice, targets multiple angiogenic pathwaysCancer Biol Ther201111223624121191188
PubMed Web of Science ®Google Scholar
BhandarkarSSArbiserJLCurcumin as an inhibitor of angiogenesisAdv Exp Med Biol200759518519517569211
PubMed Web of Science ®Google Scholar
ShanBSchaafCSchmidtACurcumin suppresess HIF1A synthesis and VEGF release in pituitary adenomasJ Endocrinol2012214338939822739211
PubMed Web of Science ®Google Scholar
LiLAhmedBMehtaKKurzrockRLiposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancerMol Cancer Ther2007641276128217431105
PubMed Web of Science ®Google Scholar
MachCMMathewLMosleySAKurzrockRSmithJADetermination of minimum effective dose and optimal dosing schedule for liposomal curcumin in a xenograft human pancreatic cancer modelAnticancer Res20092961895189919528445
PubMed Web of Science ®Google Scholar
MartinRGellerDEspatJSafety and efficacy of transarterial chemoembolization with drug-eluting beads in hepatocellular cancer: a systematic reviewHepatogastroenterology20125911325526022251546
PubMedGoogle Scholar
RheeTKYoungJYLarsonACEffect of transcatheter arterial embolization on levels of hypoxia-inducible factor-1 alpha in rabbit VX2 liver tumorJ Vasc Interv Radiol200718563964517494846
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Liposomal curcumin inhibits hypoxia-induced angiogenesis after transcatheter arterial embolization in VX2 rabbit liver tumors

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Liposomal curcumin inhibits hypoxia-induced angiogenesis after transcatheter arterial embolization in VX2 rabbit liver tumors

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date